1Fish DC, Fisher EA, Budd JH, et al. The incidence of patent foramen ovale in 1000 conseccutive patients. A contrast transesophageal echocardiographic study[J]. Chest, 1995, 107:1504-1509.
2Homma S, Di Tullio MR, Sacco RL, et al Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study[J]. Stroke, 1994, 25:582-586.
3Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolie brain imaging findings among patients with ischemic stroke[J] Stroke, 1998, 29:944-948.
4Lechat P, Lascaut G, Mas JL, et al. Prevalence of Patent foramen ovale in young patients with ischemic cerebral complications[J]. Arch Mal Coeur Vaiss, 1989, 82:847-852.
5Kizer JR, Devereux RB. Patent foramen ovale in young adults with unexplained stroke[J]. N Engl J Med, 2005, 353:2361-2372.
6Wechsler LR. PFO and stroke: what are the data?[J]. Cardiol Rev, 2008, 16:53-57.
7Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The PFO-ASA Study. A trial Septal Aneurysm[J]. Stroke, 2002, 33:706-711.
8Di Tullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population[J]. J Am Coll Cardiol, 2007, 49:797-802.
9Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study[J]. J Am Coll Cardiol, 2006, 47:440-445.
10Homma S, Di Tullio MR, Sacco RL, et al. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale[J]. Stroke, 2004, 35:2145-2149.
二级参考文献14
1Bruch L, Parsi A, Grad MO, et al. Transeatheter closure of interatrial communications for secondary preventiou of paradoxcat embolism: singlecenter experience. Circulation, 2002,105 ( 24 ) :2845-2848.
2Zhang YS, Dai ZX, Jia GL. Study develupment about Patent foramen ovale and paradoxical embolism. Chinese Heart Journal, 2001,13 (4):319-321.
3Cambier BA. Anotomophysiology of the atria itt aduh human hearts ( Phd thesis). Ghent, Belgium: University, of Ghent, 1993.
4Braun MU, Fassbender D, Sehoen SP. et at. Transcatbeter closure of Patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol,2002,39 ( 12 ) :2019-2025.
5Cabanes L, Mas J, Cohen A, et al. Atrial septal aneurysm and Patent foramen ovale as risk foctors in patients less than 55 years of age. A study using transesophageal echocardiography Stroke, 1993.24 ( 12 ) : 1865-1873.
6Jaber WA, Klein AL. How often are atrial septa] defects associated with thromboembolism? When should they be looked for? Cleveland Clinic Journal of Medicine, 2001,68( 11 ) :954-956.
7De Belder M, Tourikis L, Leech C. Patent foramen ovate-risk fector for thromboembolic events in all age groups? Circulation, 1990, 82 ( suppl 1) :109.
8Hausman D, Muegge A. Bectit( 1991 ) Pateut forameu ovate diagnosed by transesophageat echocardiography: high prevaleuce in young adults with stroke or peripheral embolism. J Am Cott Cardiot, 1991, 17 : 143A.
9Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Lausanne Stroke with paradoxical embolism study group,Stroke recurrence in patients with patent fpramen ovale: the lausanne study. Neurology, 1996, 46: 1301-1305.
10Mas JL, Zuber M. French study group on Patent foramen oxale and atrial septal aneurysm: recurrent cerebrovascular ex ents in patients with Patent foramen ovale and atrial septal aneurysm, or both and cryptogenic stroke or transit ischemic attack. AM Heart J, 1995,130 : 1083-1088.
4Domitrz I,Mieszkowski J, Kwiecinski H.The prevalence of patent foramen ovale in patients with migraine [J].Neurol Neurochir Pal, 2004,8 (5) : 89.
5Schwerzmann M, Nedltcher K, Lagger F, et al.Prevalence and size of directly dtected patent framen ovale in mi- graine with aura[J].Neurology, 2005,65 (3) : 1415.
6Tembl J,Lago A,Serila T,et al.Migraine,patent foramen o vale and migraine triggers[J].J Headache Pain,2007,8 (1): 7-12.
7Adams HP Jr , Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993,24:35-41.
